Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis

ConclusionsSARS patients who received higher cumulative doses and longer treatment durations of steroids were more likely to develop osteonecrosis, and there were no sex differences in this dose-dependent side effect. Our findings suggest that it is important to reduce osteonecrosis risk by modifying the cumulative dose and the treatment duration of steroids in SARS patients.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research